Retatrutide 10mg Australia | Silverback Peptides – Research Use Only Triple Agonist
Revolutionary Triple-Agonist Power: Retatrutide 10mg (Australia)
Unlock unprecedented metabolic research with this groundbreaking triple receptor agonist. Targeting GLP-1, GIP, and glucagon receptors simultaneously, Retatrutide offers a powerful and innovative tool for studying dramatic weight reduction, superior glycemic control, and enhanced energy expenditure . Ideal for advanced investigations into obesity, diabetes, and metabolic pathways .
For Research Use Only. Not for human consumption or medical use. This product is not approved by the TGA for personal use in Australia and is restricted to scientific research within licensed institutions only
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Retatrutide 10mg – 99% Purity (Research Use Only)
Retatrutide 10mg is a high-purity research peptide supplied for laboratory and scientific research applications. Manufactured to a verified 99% purity, this compound is intended for controlled research environments where consistency, quality, and reliability are essential.
Each vial contains 10mg of Retatrutide, produced under strict quality standards and independently tested to ensure accurate composition and purity. This product is clearly labeled and supplied exclusively for research use only.
Key Features
Compound: Retatrutide
Content: 10mg per vial
Purity: 99% verified
Form: Lyophilized powder
Testing: Independently purity tested
Use: Laboratory research only
Not for human or animal consumption
Amino Acids: The Unsung Heroes of Muscle, Mood, and Metabolism














sbp_admin –
Review Title: Reliable analytical standard for receptor binding assays
The retatrutide 10mg standard from Silverback has performed consistently in our radioligand displacement assays using recombinant GLP-1 and GIP receptors. Binding affinity measurements (Ki values) align with published literature values for this compound.
Product arrived with intact cold chain documentation and comprehensive COA. Solubility in assay buffer (PBS + 0.1% BSA) is excellent with no precipitation observed at working concentrations.
Have ordered three times without quality inconsistencies. Recommended for laboratories requiring well-characterized incretin receptor ligands for in vitro pharmacology studies.
Disclaimer: Research application only. Schedule 4 substance requiring appropriate institutional approvals.